Article

Committee: Use high-dose RT for intermediate-risk PCa

Paris-An international consensus committee has recommended that men withintermediate-risk prostate cancer be treated with high-dose 3D conformalradiotherapy-with or without hormonal therapy-rather than with combinedexternal-beam radiation and brachytherapy.

Related Videos
Couple talking with doctor | Image Credit: © Chinnapong - stock.adobe.com
Phillip M. Pierorazio, MD, answers a question during a video interview
Daniel Kwon, MD, answers a question during a Zoom video interview
Man talking with doctor | Image Credit: © RFBSIP - stock.adobe.com
Related Content
Phase 2 trial launches of autologous prostate cancer vaccine
November 27th 2024

Phase 2 trial launches of autologous prostate cancer vaccine

Hannah Clarke
The phase 2 CELLVX-230 trial is exploring the potential of FK-PC101 to delay or prevent prostate cancer recurrence following prostatectomy.
Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults
November 27th 2024

Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults

Wayne Kuang, MD Bilal Chughtai, MD
Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.
Epigenomic cfDNA may accurately assess PSMA expression, Lu-PSMA response in mCRPC
November 26th 2024

Epigenomic cfDNA may accurately assess PSMA expression, Lu-PSMA response in mCRPC

Hannah Clarke
“Our study highlights the potential of epigenomic profiling from a simple blood draw to provide a real-time, non-invasive readout of PSMA expression that corresponds with treatment response," says Jacob E. Berchuck, MD.
Former MLB player Dave Winfield shares lessons from baseball, philanthropy
November 15th 2024

Former MLB player Dave Winfield shares lessons from baseball, philanthropy

Urology Times staff
In this episode of Speaking of Urology, former MLB player Dave Winfield shares lessons he’s learned throughout his professional baseball career and his work in philanthropy.
Behavioral intervention may improve psychological distress after testicular cancer
November 25th 2024

Behavioral intervention may improve psychological distress after testicular cancer

Hannah Clarke
The study showed significant reductions in both anxiety and depressive symptoms following the intervention.
Capivasertib plus abiraterone extends rPFS in PTEN-deficient mHSPC
November 25th 2024

Capivasertib plus abiraterone extends rPFS in PTEN-deficient mHSPC

Hannah Clarke
Data from the CAPItello-281 trial also showed a trend toward an improvement in overall survival.
© 2024 MJH Life Sciences

All rights reserved.